rs10401628

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.3013+377T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.908 in 152,162 control chromosomes in the GnomAD database, including 62,801 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.91 ( 62801 hom., cov: 31)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.81

Publications

6 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.3013+377T>C intron_variant Intron 16 of 21 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.2977+377T>C intron_variant Intron 15 of 20 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.3010+377T>C intron_variant Intron 16 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.2974+377T>C intron_variant Intron 15 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.3013+377T>C intron_variant Intron 16 of 21 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.2977+377T>C intron_variant Intron 15 of 20 1 ENSP00000342838.4 P06213-2

Frequencies

GnomAD3 genomes
AF:
0.908
AC:
138096
AN:
152044
Hom.:
62751
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.939
Gnomad AMI
AF:
0.823
Gnomad AMR
AF:
0.928
Gnomad ASJ
AF:
0.926
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.937
Gnomad FIN
AF:
0.862
Gnomad MID
AF:
0.946
Gnomad NFE
AF:
0.883
Gnomad OTH
AF:
0.916
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.908
AC:
138204
AN:
152162
Hom.:
62801
Cov.:
31
AF XY:
0.908
AC XY:
67538
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.939
AC:
39008
AN:
41534
American (AMR)
AF:
0.928
AC:
14182
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.926
AC:
3215
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5167
AN:
5170
South Asian (SAS)
AF:
0.936
AC:
4510
AN:
4816
European-Finnish (FIN)
AF:
0.862
AC:
9108
AN:
10570
Middle Eastern (MID)
AF:
0.939
AC:
276
AN:
294
European-Non Finnish (NFE)
AF:
0.883
AC:
60050
AN:
67998
Other (OTH)
AF:
0.917
AC:
1937
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
652
1304
1957
2609
3261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.894
Hom.:
42234
Bravo
AF:
0.914
Asia WGS
AF:
0.962
AC:
3345
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.24
DANN
Benign
0.74
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10401628; hg19: chr19-7126218; API